Cytomx Therapeutics (CTMX)'s 30-day implied volatility (IV30) was 147.9% at the close on October 30, 2026, up from 133.6% the day before, against a 52-week range of 48.5% to 336.0%. Its 20-day historical volatility was 64.1%.
Data as of October 30, 2026.